| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | 0.0039 | 0.9 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0044 | 0.9 |
| mRNA | Epothilone B | FIMM | pan-cancer | AAC | 0.019 | 0.9 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | -0.0044 | 0.9 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | 0.0042 | 0.9 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | 0.0029 | 0.9 |